Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Sees Large Decline in Short Interest

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 30,788 shares, a decrease of 33.1% from the November 30th total of 45,995 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average trading volume of 22,913 shares, the days-to-cover ratio is currently 1.3 days. Based on an average trading volume of 22,913 shares, the days-to-cover ratio is currently 1.3 days. Currently, 0.1% of the shares of the company are sold short.

Institutional Investors Weigh In On Zhengye Biotechnology

A number of hedge funds have recently made changes to their positions in the business. Geode Capital Management LLC bought a new position in Zhengye Biotechnology in the 2nd quarter worth approximately $174,000. Invesco Ltd. acquired a new position in Zhengye Biotechnology during the 2nd quarter worth $220,000. Jane Street Group LLC bought a new position in shares of Zhengye Biotechnology in the second quarter worth $1,158,000. WINTON GROUP Ltd acquired a new position in shares of Zhengye Biotechnology during the third quarter valued at $56,000. Finally, Citadel Advisors LLC bought a new stake in shares of Zhengye Biotechnology during the third quarter valued at about $31,000.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Zhengye Biotechnology in a research note on Tuesday, October 14th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

Zhengye Biotechnology Trading Down 8.9%

ZYBT stock opened at $1.53 on Monday. The firm’s 50-day simple moving average is $2.13 and its 200 day simple moving average is $4.91. Zhengye Biotechnology has a fifty-two week low of $1.40 and a fifty-two week high of $14.30. The company has a quick ratio of 1.10, a current ratio of 1.49 and a debt-to-equity ratio of 0.01.

About Zhengye Biotechnology

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.